Table 1 Baseline characteristics of the 71,583 study CDR at the date of dialysis onset
From: Evolving impact of the COVID-19 pandemic in chronic dialysis recipients in France
Variable | Variable Value | All CDR (n = 71,583) | CDR with an incidence date during the pre-pandemic period (n = 53,405) | CDR with an incidence date during the pandemic period (n = 18,178) | p value |
|---|---|---|---|---|---|
Age group | <0.01 | ||||
18–44 | 5591 (7.8%) | 4153 (7.8%) | 1438 (7.9%) | ||
45–54 | 6069 (8.5%) | 4545 (8.5%) | 1584 (8.4%) | ||
55–64 | 11,218 (15.7%) | 8404 (15.7%) | 2814 (15.5%) | ||
65–74 | 19,889 (27.2%) | 14,548 (27.2%) | 5341 (29.4%) | ||
75–84 | 20,082 (28.3%) | 15,126 (28.3%) | 4956 (27.3%) | ||
≥ 85 | 8734 (12.4%) | 6629 (12.4%) | 2105 (11.6%) | ||
Sex | 0.01 | ||||
Male | 46,099 (64.1%) | 34,252 (64.1%) | 11,847 (64.4%) | ||
Female | 25,484 (35.9%) | 19,153 (35.9%) | 6331 (35.6%) | ||
Diabetes | <0.01 | ||||
No | 38,244 (53.9%) | 28,810 (53.9%) | 9434 (51.9%) | ||
Yes | 33,339 (46.1%) | 24,595 (46.1%) | 8744 (48.1%) | ||
Chronic cardiovascular disease | 0.03 | ||||
No | 36,060 (50.1%) | 26,774 (50.1%) | 9286 (51.1%) | ||
Yes | 35,523 (49.9%) | 26,631 (49.9%) | 8892 (48.9%) |
